Your Messages Inbox
Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
See Latest ArticlesThe effects of an olmesartan medoxomil–based treatment algorithm on 24-hour blood pressure levels in elderly patients aged 65 and older
The Journal of Clinical Hypertension, 07/01/09
Kereiakes DJ et al. – An olmesartan medoxomil (OM)-based treatment algorithm effectively lowers blood pressure (BP) in an elderly pt population throughout 24-hr dosing interval without compromising tolerability.
Methods- Study of the effect of OM ± hydrochlorothiazide (HCTZ) on mean 24-hr ambulatory BP, mean seated cuff (Se)BP, and SeBP goal achievement in hypertensive pts age ≥65 yrs
- After 2- to 3-wk placebo run-in, OM 20 mg, uptitrated to 40 mg, then added HCTZ 12.5 mg to 25 mg stepwise at 3-wk intervals if SeBP remained ≥120/70 mm Hg
- Primary endpoint: change from baseline in mean 24-hr ambulatory systolic BP
- At study end, mean 24-hr ambulatory BP decreased by 25.7/12.3 mm Hg (150 pts) and mean SeBP by 25.4/10.5 mm Hg (176 pts)
- Drug-related treatment-emergent adverse events, most commonly dizziness (3.4%), hypotension (2.2%), and headache (1.1%), in 11.8% of pts
Related Articles
Benefits of the angiotensin II receptor antagonist olmesartan in controlling hypertension and cerebral hemodynamics after stroke
Hypertension Research, 11/11/09
Relevance Score: 87%
Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension
Hypertension Research, 11/10/09
Relevance Score: 84%
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 11/10/09
Relevance Score: 80%
Angiotensin II receptor blocker attenuates PDGF-induced mesangial cell migration in a receptor-independent manner
Nephrology Dialysis Transplantation, 10/08/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Chronic Obstructive Pulmonary Disease: Role of Bacteria and Updated Guide to Antibacterial Selection in the Older Patient
Drugs & Aging, 11/25/09
Today in Geriatrics...keeping you current
Receive free subspecialty "5-minute updates" via email
Extremes of Endogenous Testosterone Are Associated with Increased Risk of Incident Coronary Events in Older Women
Journal of Clinical Endocrinology and Metabolism, 11/25/09
Smoking Predicts Incident Fractures in Elderly Men: Mr OS Sweden
Journal of Bone and Mineral Research, 11/25/09
Prediction of institutionalization in the elderly. A systematic review
Age and Aging, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor